Skip to content
  • Reports
  • Podcast Subscribe
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » Merck

Merck

ADVERTISEMENT
In Depth

The future of cancer treatment: Exploiting cancer’s key vulnerabilities

By Victoria Zazulina, M.D., head of development unit, oncology, for the healthcare business of Merck…

By External Contributor
February 1, 2023 - 4 minutes
News and Trends

Mersana Therapeutics and Merck to develop novel ADCs

Mersana Therapeutics, Inc. has announced a research collaboration and commercial license agreement with a subsidiary…

By Jim Cornall
December 23, 2022 - 3 minutes
News and Trends

Merck and Kelun-Biotech collaborating on seven ADC cancer candidates 

Merck (MSD outside of the U.S. and Canada), and Kelun-Biotech (a holding subsidiary of Sichuan…

By Jim Cornall
December 23, 2022 - 2 minutes
Sponsored by Merck

Infographic: your gene therapy manufacturing success recipe

By 2026, pharma industry insiders anticipate cell and gene therapy sales to significantly increase, with…

By Sudha Sundaram
November 14, 2022 - 2 minutes
News and Trends

Merck contributing to Jacobio Pharma colorectal cancer clinical trial

Jacobio announced it has entered into a clinical trial collaboration agreement with Merck on a…

By Jim Cornall
October 13, 2022 - 2 minutes
News and Trends

TILT and MSD working on immunotherapy trial for non-small cell lung cancer

TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapies, has signed a second clinical trial…

By Jim Cornall
September 26, 2022 - 3 minutes
News and Trends

Astellas, Seagen and Merck give details on urothelial cancer treatment

Astellas Pharma Inc., Seagen Inc. and Merck (known as MSD outside of the U.S. and…

By Jim Cornall
September 12, 2022 - 5 minutes
News and Trends

Investment of €130M made by Merck’s MilliporeSigma for life-saving therapies

An investment of €130 million ($130 million) has been invested in Molsheim, France to strengthen…

By Liza Laws
September 8, 2022 - 2 minutes
News and Trends

CRISPR/CAS9 strategic alliance between Sigma-Aldrich and genOway expanded

Sigma-Aldrich Co LLC, along with genOway, a preclinical research model space company, announced today (September…

By Liza Laws
September 8, 2022 - 3 minutes
News and Trends

Merck puts up to $37B into Orna Therapeutics circular RNA collaboration

Merck, also known as MSD outside the U.S. and Canada, and Orna Therapeutics, a biotech…

By Jim Cornall
August 16, 2022 - 3 minutes
News and Trends

Immutep reports positive data from cancer study

Immutep Limited, an Australian biotech company developing LAG-3-related immunotherapy treatments for cancer and autoimmune disease,…

By Jim Cornall
August 1, 2022 - 4 minutes
News and Trends

BioMed X Institute and Merck start new oncology research project

BioMed X, a German independent research institute, has started a new research project ‘Extrachromosomal DNA…

By Jim Cornall
August 1, 2022 - 3 minutes
  • 1
  • 2
  • 3
  • …
  • 8
  • Next Page »
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Gene therapy Synthetic biology
    Labiotech.eu
    • Log In

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast
    • Biotech Events
    • Awareness Days